Quent Capital’s Ascendis Pharma A/S ASND Stock Holding History

Quent Capital’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.2K	Sell	27 -11	-29%	-$2.57K	﹤0.01%	1309
2026 Q1	$8.69K	Hold	38	–	–	﹤0.01%	1186
2025 Q4	$8.1K	Hold	38	–	–	﹤0.01%	1193
2025 Q3	$7.55K	Buy	+38	New	+$7.09K	﹤0.01%	1075
2025 Q2	–	Sell	-38	Closed	-$5.92K	–	353
2025 Q1	$5.92K	Hold	38	–	–	﹤0.01%	989
2024 Q4	$5.23K	Hold	38	–	–	﹤0.01%	1029
2024 Q3	$5.67K	Hold	38	–	–	﹤0.01%	1081
2024 Q2	$5.18K	Hold	38	–	–	﹤0.01%	1080
2024 Q1	$5.74K	Hold	38	–	–	﹤0.01%	1089
2023 Q4	$4.79K	Hold	38	–	–	﹤0.01%	1084
2023 Q3	$3.56K	Buy	38 +11	+41%	+$1.03K	﹤0.01%	1106
2023 Q2	$2.41K	Buy	+27	New	+$2.35K	﹤0.01%	1166

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Quent Capital's ASND Position: Q2 2026 in Review

Quent Capital reduced its Ascendis Pharma A/S (ASND) stake by 29% in Q2 2026, selling an estimated $2.57K and leaving 27 shares worth $7.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1309.

Quent Capital first reported a position in ASND in Q2 2023 and has held it in 12 quarters since. The position peaked at $8.69K in Q1 2026. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Quent Capital held 27 shares of Ascendis Pharma A/S worth $7.2K as of Q2 2026.
Quent Capital sold 11 Ascendis Pharma A/S shares in Q2 2026, an estimated $2.57K.
Ascendis Pharma A/S made up ﹤0.01% of Quent Capital's portfolio in Q2 2026, its #1309 holding.
Quent Capital first reported a position in Ascendis Pharma A/S in Q2 2023 and has held it in 12 quarters since.
Quent Capital's Ascendis Pharma A/S position peaked at $8.69K in Q1 2026.
312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Quent Capital's 13F filing for Q2 2026, filed 7 Aug 2026.